Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer

Xihuang pill (XHP), a traditional Chinese herbal formula, has been clinically used as an adjuvant therapy against triple-negative breast cancer (TNBC) via inhibiting cancer cell invasion and proliferation, as well as promoting cancer cell apoptosis. However, its anti-TNBC bio-active ingredients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xingchao, Zhang, Jimei, Zhang, Zhenhua, Wang, Meng, Liu, Yaping, Li, Xiangqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291799/
https://www.ncbi.nlm.nih.gov/pubmed/33092442
http://dx.doi.org/10.1080/21655979.2020.1834726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291799/
https://www.ncbi.nlm.nih.gov/pubmed/33092442
http://dx.doi.org/10.1080/21655979.2020.1834726

Ejemplares similares